AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 196 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2024. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,468,712 | +35.6% | 133,873 | -15.3% | 0.00% | 0.0% |
Q1 2024 | $4,031,522 | +133.6% | 157,975 | -17.2% | 0.00% | – |
Q4 2023 | $1,726,089 | +34.5% | 190,728 | -5.2% | 0.00% | – |
Q3 2023 | $1,283,190 | -48.3% | 201,127 | -10.2% | 0.00% | -100.0% |
Q2 2023 | $2,483,029 | +22.3% | 223,898 | +69.3% | 0.00% | 0.0% |
Q1 2023 | $2,029,624 | +71.5% | 132,223 | +147.9% | 0.00% | – |
Q4 2022 | $1,183,327 | +34.2% | 53,327 | -1.3% | 0.00% | – |
Q3 2022 | $882,000 | -26.4% | 54,039 | -34.5% | 0.00% | – |
Q2 2022 | $1,199,000 | -19.9% | 82,544 | +1.9% | 0.00% | – |
Q1 2022 | $1,496,000 | -49.9% | 81,009 | -35.6% | 0.00% | -100.0% |
Q4 2021 | $2,989,000 | +1.0% | 125,770 | +4.7% | 0.00% | 0.0% |
Q3 2021 | $2,958,000 | +79.4% | 120,112 | +80.1% | 0.00% | – |
Q2 2021 | $1,649,000 | -13.3% | 66,709 | -23.5% | 0.00% | – |
Q1 2021 | $1,903,000 | -7.8% | 87,241 | +7.8% | 0.00% | – |
Q4 2020 | $2,065,000 | +37.5% | 80,924 | +51.6% | 0.00% | – |
Q3 2020 | $1,502,000 | – | 53,367 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 926,454 | $25,556,000 | 5.11% |
EcoR1 Capital, LLC | 2,103,950 | $59,458,000 | 4.39% |
RTW INVESTMENTS, LP | 3,995,000 | $103,863,000 | 2.92% |
Cormorant Asset Management, LP | 2,514,547 | $67,804,000 | 2.59% |
Boxer Capital, LLC | 1,121,327 | $31,689,000 | 1.39% |
ACUTA CAPITAL PARTNERS, LLC | 117,500 | $3,321,000 | 0.96% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 877,011 | $24,784,000 | 0.72% |
Pinz Capital Management, LP | 50,000 | $1,413,000 | 0.65% |
Matrix Capital Management Company, LP | 1,200,000 | $33,912,000 | 0.53% |
Perceptive Advisors | 1,235,818 | $31,613,000 | 0.51% |